Cell and Organ Transplantology. 2022; 10(1):10-16.
DOI: 10.22494/cot.v10i1.139
The efficacy of cryopreserved ex vivo expanded rat bone marrow-derived multipotent mesenchymal stromal cells in the repair of radiation injuries in rats
Uzlenkova N., Skorobogatova N., Kryvko A., Krasnoselsky M.
- Grigoriev Institute for medical Radiology of the National Academy of Medical Sciences of Ukraine, Kharkiv, Ukraine
Abstract
At present, applying multipotent mesenchymal stromal cells (MSCs) as cell therapy for radiation damages have gained increasing attention since current medical management remains far from satisfactory.
The aim of the study is to examine the efficacy of cryopreserved ex vivo expanded bone marrow-derived MSCs (rBM-MSCs) to the repair of radiation injuries on rat models of total and local radiation exposure.
Materials and methods. The MSCs were derived from bone marrow of non-irradiated female albino rats aged 4 months, short-term ex vivo expanded for two passages and cryopreserved under dimethyl sulfoxide cryoprotection for low temperature storage at -70 oC for 6-12 months. The cryopreserved samples from each batch of rBM-MSCs culture were tested for the viability and functional characteristics before being transplanted to rats in experiments in vivo. The acute radiation damages in rats were modeled by total body irradiation (TBI) at doses of 5.5 Gy (TBI 5.5) and 7.0 Gy (TBI 7.0) and locally irradiated in the right hip skin at a dose of 50 Gy. The cryopreserved rBM-MSCs (1.5•106 and 0.5•106 cells/animal) were intravenously transplanted within 24 h following TBI and locally injected (twice 1.5•106 Cells/animals) on days 15 and 21 following thigh irradiation. The efficacy of cryopreserved rBM-MSCs was assessed by survival and hematological study as well as the irradiated skin wound healing assay.
Results. The cryopreserved ex vivo expanded rBM-MSCs were characterized by high level of functional activity with cell viability about 80 %, include at least 8.5 % of the colony forming MSCs and MSCs with ability to adipogenic and osteogenic differentiation In TBI 5.5 rats, cryopreserved transplanted rBM-MSCs (1.5·106 cells/animal) prevented acute leukopenia in the first critical days of the radiation injury by increasing the number of leukocytes by 3.7 times on day 2 and contributed to a more complete recovery of hematological disorders by increasing the BM cells number and platelet count on day 22, which led to the increase of the increase of overall survival up to 100 % with a regain of body weight. In TBI 7.0 rats, the lower transplanted dose of rBM-MSCs (0.5•106 cells/animal) was more effective in terms of general recovery and extended the overall survival time for 6 days. The locally injected rBM-MSCs (twice 1.5•106 cells/animals) reduced the severity and promoted the healing of radiation skin wounds according to the results of scoring and wound size assay.
Conclusion. The present study confirms that the cryopreserved ex vivo expanded rBM-MSCs were functionally complete for the therapeutic use on rat models of experimental radiation damage and were effective for the recovery of hematopoietic system and severe skin wound after radiation exposure.
Key words: bone marrow-derived multipotent mesenchymal stromal cells; cell expansion ex vivo; cell cryopreservation; radiation injury
Full Text PDF1. McBride WH, Schaue D. Radiation‐induced tissue damage and response. J Pathol. 2020; 250 (5):647-655.https://doi 10.1002/path.5389 https://doi.org/10.1002/path.5389 PMid:31990369 PMCid:PMC7216989 |
||||
2. Hofer M, Pospisil M, Komurkova D, Hoferova Z. Granulocyte colony‐stimulating factor in the treatment of acute radiation syndrome: a concise review. Molecules. 2014;19:4770-8. https://doi: 10.3390/molecules19044770. https://doi.org/10.3390/molecules19044770 PMid:24743934 PMCid:PMC6270858 |
||||
3. MacVittie TJ, Farese AM, Jackson W 3rd. Defining the full therapeutic potential of recombinant growth factors in the post radiation‐accident environment: the effect of supportive care plus administration of G‐CSF. Health Phys. 2005;89:546-555. https://doi: 10.1097/01.hp.0000173143.69659.5b. https://doi.org/10.1097/01.HP.0000173143.69659.5b PMid:16217198 |
||||
4. DiCarlo AL, et al. Cellular therapies for treatment of radiation injury: report from a NIH/NIAID and IRSN workshop. Radiat. Res. 2017; 188:54-75.https://doi: 10.1667/RR14810.1. Epub 2017 Jun 12. https://doi.org/10.1667/RR14810.1 PMid:28605260 PMCid:PMC5564392 |
||||
5. Rios C, Jourdain J-R, DiCarlo AL. Cellular therapies for treatment of radiation injury after a mass casualty incident. Radiat. Res. 2017 https://doi.org/10.1667/RR14835.1 PMid:28609636 PMCid:PMC5564290 |
||||
188 (2):242-5. https://doi: 10.1667/RR14835.1. Epub 2017 Jun 13. https://doi.org/10.1667/RR14835.1 PMid:28609636 PMCid:PMC5564290 |
||||
6. Pittenger MF, et al. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen. Med. 2019;4:22-36. https://doi: 10.1038/s41536-019-0083-6. eCollection 2019. https://doi.org/10.1038/s41536-019-0083-6 PMid:31815001 PMCid:PMC6889290 |
||||
7. Qi K, Li N, Zhang Z, Melino G. Tissue regeneration: The crosstalk between mesenchymal stem cells and immune response. Cell Immunol. 2018;326:86-93. https://doi: 10.1016/j.cellimm.2017.11.010. https://doi.org/10.1016/j.cellimm.2017.11.010 PMid:29221689 |
||||
8. Najar M, Bouhtit F, Melki R, Afif H, Hamal A, Fahmi H, Merimi M, Lagneaux L. Mesenchymal Stromal Cell-Based Therapy: New Perspectives and Challenges. J Clin Med. 2019;8:626. https://doi: 10.3390/jcm8050626 https://doi.org/10.3390/jcm8050626 PMid:31071990 PMCid:PMC6572531 |
||||
9. Galipeau J,Sensébé L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018; 22 (6):824-833. https://doi:0.1016/j.stem.2018.05.004. https://doi.org/10.1016/j.stem.2018.05.004 PMid:29859173 PMCid:PMC6434696 |
||||
10. NajiA,EitokuM,FavierB,DeschaseauxF et al. Biological functions of mesenchymal stem cells and clinical implications. Cell Mol Life Sci. 2019;76 (17):3323-3348. https://doi: 10.1007/s00018-019-03125-1. https://doi.org/10.1007/s00018-019-03125-1 PMid:31055643 |
||||
11. Lotty A, Salama M, Zahran F, et. al. Characterization of Measenchymal Stem Cells Derived from Rat Bone Marrow and Adipose Tissue: a Comparative Study. Int J Stem Cells. 2014;7 (2):135-142.https://doi: 10.15283/ijsc.2014.7.2.135. https://doi.org/10.15283/ijsc.2014.7.2.135 PMid:25473451 PMCid:PMC4249896 |
||||
12. Viswanathan S, Shi Y, Galipeau J, Krampera M, Leblanc K, Martin I, et al. Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT (R)) Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy. 2019; 21:1019-24.https://doi: 10.1016/j.jcyt.2019.08.002. https://doi.org/10.1016/j.jcyt.2019.08.002 PMid:31526643 |
||||
13. Wilson A, Webster A, Genever P. Nomenclature and heterogeneity: consequences for the use of mesenchymal stem cells in regenerative medicine. Regen Med. 2019;14:595-611.https://doi: 10.2217/rme-2018-0145. Epub 2019 May 22 https://doi.org/10.2217/rme-2018-0145 PMid:31115266 PMCid:PMC7132560 |
||||
14. Moll G, Hoogduijn MJ, Ankrum JA. Editorial: Safety, efficacy and mechanisms of action of mesenchymal stem cell therapies. Front Immunol. 2020;11:243. https://doi: 10.3389/fimmu.2020.00243. https://doi.org/10.3389/fimmu.2020.00243 PMid:32133010 PMCid:PMC7040069 |
||||
15. Peter RU, Panizzon RG, Seegenschmiedt MH. Diagnosis and treatment of cutaneous radiation injuries. In: Panizzon RG, Seegenschmiedt MH, editors. Radiation treatment and radiation reactions in dermatology. Berlin: Springer-Verlag Berlin Heidelberg.2015. p. 185-188. https://doi: 10.18632/aging.103932. https://doi.org/10.18632/aging.103932 |
||||
16. Lukomska B, Stanaszek L, Zuba-Surma E, Legosz P, Sarzynska S, Drela K. Challenges and controversies in human mesenchymal stem cell therapy. Stem Cells Int. 2019:9628536. https:// doi: 10.1155/2019/9628536. eCollection 2019. https://doi.org/10.1155/2019/9628536 PMid:31093291 PMCid:PMC6481040 |
||||
17. Shende P., Gupta H., Gaud R.S. Cytotherapy using stromal cells: Current and advance multi-treatment approaches. Biomed. Pharmacother. 2018;97:38-44. https:// doi: 10.1016/j.biopha.2017.10.127. https://doi.org/10.1016/j.biopha.2017.10.127 PMid:29080456 |
||||
18. Dominici M., Blanc K Le, Mueller I. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8 (4); 315-317. https://doi: 10.1080/14653240600855905. https://doi.org/10.1080/14653240600855905 PMid:16923606 |
||||
19. Wei J, Meng L, Hou X et al. Radiation-induced skin reactions: mechanism and treatment. Cancer Manag Res. 2019; 11: 167-177. https://doi: 10.2147/CMAR.S188655. https://doi.org/10.2147/CMAR.S188655 PMid:30613164 PMCid:PMC6306060 |
||||
20. Kumar S, Kolozsvary A, Kohl R, Lu M, Brown S, Kim JH. Radiation-induced skin injury in the animal model of scleroderma: implications for post-radiotherapy fibrosis. Radiat Oncol 2008; 3:40 https:// doi:10. 1186/1748-717X-3-40. https://doi.org/10.1186/1748-717X-3-40 PMid:19025617 PMCid:PMC2599892 |
||||
21. Pittenger MF. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJRegen. Med. 2019;4:22-36. https:// doi: 10.1038/s41536-019-0083-6. eCollection 2019. https://doi.org/10.1038/s41536-019-0083-6 PMid:31815001 PMCid:PMC6889290 |
||||
22. Weiss ARR, Dahlke MH. Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs. Front. Immunol. 2019;10:1191.https:// doi: 10.3389/fimmu.2019.01191. eCollection 2019. https://doi.org/10.3389/fimmu.2019.01191 PMid:31214172 PMCid:PMC6557979 |
||||
23. Zhao L, Chen S, Yang P, Cao H, Li L. The role of mesenchymal stem cells in hematopoietic stem cell transplantation:prevention and treatment of graft-versus-host disease. Stem Cell Res Ther. 2019;10 (1):182 DOI: https:// doi:10.1186/s13287-019-1287-9 https://doi.org/10.1186/s13287-019-1287-9 PMid:31227011 PMCid:PMC6588914 |
||||
24. Ullah M, Liu DD, Thakor AS. Mesenchymal Stromal Cell Homing: Mechanisms and Strategies for Improvement. iScience. 2019;15:421-438. https:// doi:10.1016/j.isci.2019.05.004. Epub 2019 May 9. https://doi.org/10.1016/j.isci.2019.05.004 PMid:31121468 PMCid:PMC6529790 |
||||
25. Hu KX, Sun QY, Gu M, Ai HS. The radiation protection and therapy effects of mesenchymal stem cells in mice with acute radiation injury. Br J Radiol. 2010;83 (985):52-58. https:// doi:10.1259/bjr/61042310 https://doi.org/10.1259/bjr/61042310 PMid:20139249 PMCid:PMC3487250 |
||||
26. Lange C, Brunswig-Spickenheier B, Cappallo-Obermann H et al. Radiation rescue: mesenchymal stromal cells protect from lethal irradiation. PLoS One. 2011; 6:e14486. https:// doi:10.1371/journal.pone.0014486 https://doi.org/10.1371/journal.pone.0014486 PMid:21245929 PMCid:PMC3016319 |
||||
27. Guerrouahen BS, Sidahmed H, Al Sulaiti A, Al Khulaifi M, Cugno C. Enhancing Mesenchymal Stromal Cell Immunomodulation for Treating Conditions Influenced by the Immune System. Stem Cells Int. 2020; 11:345-361. https://doi.org/10.1186/s13287-020-01855-9 https://doi.org/10.1186/s13287-020-01855-9 PMid:32771052 PMCid:PMC7414268 |
||||
28. Zhou Y, Yamamoto Y, Xiao Z, Ochiya T. The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity. J. Clin. Med. 2019;8:1025. https://doi: 10.3390/jcm8071025. https://doi.org/10.3390/jcm8071025 PMid:31336889 PMCid:PMC6678920 |
||||
29. Donnelly EH, Nemhauser JB, Smith JM, Kazzi ZN, Farfan EB, Chang AS, et al. Acute radiation syndrome: assessment and management. South Med J. 2010; 103:541-546. https://doi: 10.1097/SMJ.0b013e3181ddd571. https://doi.org/10.1097/SMJ.0b013e3181ddd571 PMid:20710137 |
||||
30. Hopewell JW. The Skin: Its Structure and Response to Ionizing Radiation. International Journal of Radiation Biology. 1990; 57:751-773. https:// doi: 10.1080/09553009014550911. https://doi.org/10.1080/09553009014550911 PMid:1969905 |
||||
31. Jimenez-Puerta GJ, Marchal JA, López-Ruiz E et al. Role of Mesenchymal Stromal Cells as Therapeutic Agents: Potential Mechanisms of Action and Implications in Their Clinical Use. J. Clin. Med. 2020; 9:445-461. https://doi:10.3390/jcm9020445 https://doi.org/10.3390/jcm9020445 PMid:32041213 PMCid:PMC7074225 |
||||
32. Rittie L. Cellular mechanisms of skin repair in humans and other mammals. 2016;10 (2):103-120. https:// doi: 10.1007/s12079-016-0330-1. https://doi.org/10.1007/s12079-016-0330-1 PMid:27170326 PMCid:PMC4882309 |
||||
33. François S, Bensidhoum M, Mouiseddine M, et al. Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promote their widespread engraftment to multiple to organs: A study of their quantitative distribution after irradiation damage. Stem Cells. 2006;24 (4):1020-1029 https:// doi: 10.1634/stemcells.2005-0260. Epub 2005 Dec 8. https://doi.org/10.1634/stemcells.2005-0260 PMid:16339642 |
||||
34. Hocking AM. The role of chemokines in mesenchymal stem cell homing to wounds. Adv Wound Care. 2015;4:623-630.https:// doi: 10.1089/wound.2014.0579 https://doi.org/10.1089/wound.2014.0579 PMid:26543676 PMCid:PMC4620518 |
||||
35. Im G J, Kim J H, Wu HG, Hwang S J/ Effect of Mesenchymal Stem Cells and Platelet-Derived Growth Factor on the Healing of Radiation Induced Ulcer in Rats. Tissue Eng. Regen. Med. 2016;13 (1):78-90. http://dx.doi.org/10.1007/s13770-015-0055-x https://doi.org/10.1007/s13770-015-0055-x PMid:30603388 PMCid:PMC6170994 |
||||
36. Isakson M, Blacam C, Whelan D, McArdle A, Clover AJP. Mesenchymal Stem Cells and Cutaneous Wound Healing: Current Evidence and Future Potential. Stem Cells International. 2015; 2015:831095. https:// doi:10.1155/2015/831095. https://doi.org/10.1155/2015/831095 PMid:26106431 PMCid:PMC4461792 |
||||
Uzlenkova N, Skorobogatova N, Kryvko A, Krasnoselsky M. The efficacy of cryopreserved ex vivo expanded rat bone marrow-derived multipotent mesenchymal stromal cells in the repair of radiation injuries in rats. Cell Organ Transpl. 2022; 10(1):10-16. Available from: https://doi.org/10.22494/cot.v10i1.139
Is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)